Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1‐year outcomes from the GReek AntiPlatElet (GRAPE) Registry
Journal of Thrombosis and Haemostasis2016Vol. 14(6), pp. 1146–1154
Citations Over TimeTop 10% of 2016 papers
D. Alexopoulos, Ioanna Xanthopoulou, Spyridon Deftereos, Michalis Hamilos, George Sitafidis, John Kanakakis, Ioanna Pentara, Manolis Vavouranakis, Periklis Davlouros, George Hahalis, John Goudevenos
Related Papers
- → Development and Clinical use of Prasugrel and Ticagrelor(2012)29 cited
- → Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor(2015)31 cited
- → Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor(2011)6 cited
- → Prasugrel vs. Ticagrelor in acute coronary syndromes: Which one to choose?(2011)5 cited
- → TCTAP A-027 Comparison of On-treatment Platelet Reactivity After One-month Use of Clopidogrel, Prasugrel or Ticagrelor in Koreans with Acute Coronary Syndromes(2014)2 cited